CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
A Phase 1 study to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activities of daily oral BAL101553, a novel tumor checkpoint controller (TCC) in adult patients with advanced solid tumors.
Authors
Alexandar Tzankov
Alison L. Hannah
+18Â more
Anne Schmitt-Hoffmann
Donna Crawford
Elizabeth R. Plummer
Felix Bachmann
Heidi A Lane
Jessica Brown
Juanita Lopez
Manolo D'Arcangelo
Marc Frederick Engelhardt
Martina Maurer
Nikolaos Diamantis
Paul Gougis
Rebecca Sophie Kristeleit
Sarah Slater
Sola Adeleke
Stephanie Anderson
T.R. Jeffry Evans
Yvette Drew
Publication date
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 25/10/2020